52 related articles for article (PubMed ID: 38690065)
1. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cleaved caspase-3 and Ki-67 index on diagnostic biopsy in response to neoadjuvant chemotherapy in the context of post-treatment tumour ypT stage, ypN stage, grade, and molecular subtype.
Nanev V; Milev H; Dimitrova D; Naneva S; Strashilov SA; Yordanov A; Mihailova M; Ivanova S; Karcheva M; Ivanov I
Prz Menopauzalny; 2024 Mar; 23(1):31-40. PubMed ID: 38690065
[TBL] [Abstract][Full Text] [Related]
3. Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy.
Harter D; O'Connor SM; Hertel JD; Calhoun BC
Histopathology; 2023 Sep; 83(3):453-464. PubMed ID: 37256703
[TBL] [Abstract][Full Text] [Related]
4. The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer.
Teleki I; Krenacs T; Szasz MA; Kulka J; Wichmann B; Leo C; Papassotiropoulos B; Riemenschnitter C; Moch H; Varga Z
BMC Cancer; 2013 Feb; 13():50. PubMed ID: 23374644
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis.
Miglietta L; Vanella P; Canobbio L; Naso C; Cerisola N; Meszaros P; Parodi MA; Morabito F
Oncology; 2010; 79(3-4):255-61. PubMed ID: 21372600
[TBL] [Abstract][Full Text] [Related]
6. [Effect of neoadjuvant chemotherapy on histologic grade and expression of biological markers in breast cancer].
Yin HF; Wang YH; Qin XQ; Zhang H; Li T; Ye JM; Liu YH
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):858-62. PubMed ID: 20137353
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
8. How does caspases regulation play role in cell decisions? apoptosis and beyond.
Ghorbani N; Yaghubi R; Davoodi J; Pahlavan S
Mol Cell Biochem; 2023 Nov; ():. PubMed ID: 37976000
[TBL] [Abstract][Full Text] [Related]
9. Physiological functions and roles in cancer of the proliferation marker Ki-67.
Andrés-Sánchez N; Fisher D; Krasinska L
J Cell Sci; 2022 Jun; 135(11):. PubMed ID: 35674256
[TBL] [Abstract][Full Text] [Related]
10. The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
Zhang A; Wang X; Fan C; Mao X
Front Endocrinol (Lausanne); 2021; 12():687244. PubMed ID: 34803903
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemotherapy for Breast Cancer: Moving Beyond Pathological Complete Response in the Molecular Age.
Provenzano E
Acta Med Acad; 2021 Apr; 50(1):88-109. PubMed ID: 34075766
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis.
Mrouj K; Andrés-Sánchez N; Dubra G; Singh P; Sobecki M; Chahar D; Al Ghoul E; Aznar AB; Prieto S; Pirot N; Bernex F; Bordignon B; Hassen-Khodja C; Villalba M; Krasinska L; Fisher D
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33658388
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.
Nielsen TO; Leung SCY; Rimm DL; Dodson A; Acs B; Badve S; Denkert C; Ellis MJ; Fineberg S; Flowers M; Kreipe HH; Laenkholm AV; Pan H; Penault-Llorca FM; Polley MY; Salgado R; Smith IE; Sugie T; Bartlett JMS; McShane LM; Dowsett M; Hayes DF
J Natl Cancer Inst; 2021 Jul; 113(7):808-819. PubMed ID: 33369635
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer.
Wang H; Mao X
Drug Des Devel Ther; 2020; 14():2423-2433. PubMed ID: 32606609
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
